Technology
Health
Biotechnology
NovaBay Pharmaceuticals
$1.269876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.07 (-5.26%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell NBY and other stocks, options, ETFs, and crypto commission-free!
About NBY
NovaBay Pharmaceuticals, Inc., also called NovaBay Pharmaceuticals, is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. Read More The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.
Employees
70
Headquarters
Emeryville, California
Founded
2000
Market Cap
22.74M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
683.51K
High Today
$1.32
Low Today
$1.24
Open Price
$1.32
Volume
297.12K
52 Week High
$4.04
52 Week Low
$0.229
Collections
Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
US
North America
Price Paid on Robinhood
35% Lower
Right Now
52 Week Low
$0.71
Average Price Paid
$1.94
52 Week High
$3.75
NBY Earnings
-$0.28
-$0.18
-$0.08
$0.02
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 6, After Hours